| |
| |
|
| Insider
Information: |
Stump David C |
| Relationship: |
Director |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
97,833 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$115,068 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
97,833 |
|
|
| Total
Value |
$115,068 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Human Genome Sciences Inc |
HGSI |
Exec. Vice President |
2012-07-30 |
0 |
2012-07-30 |
0 |
Premium* |
|
|
Dendreon Corp |
DNDN |
Director |
2014-01-03 |
82,047 |
2010-06-02 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2020-07-02 |
0 |
2016-06-17 |
0 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
|
2024-05-31 |
11,286 |
2022-06-03 |
0 |
Premium* |
|
|
Macrogenics Inc |
MGNX |
Director |
2024-05-20 |
4,500 |
2024-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
27 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HGSI |
Human Genome Sciences Inc |
Exec. Vice President |
• – – |
2005-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
49,576 |
|
- |
|
| HGSI |
Human Genome Sciences Inc |
Exec. Vice President |
• – – |
2008-09-23 |
4 |
D |
$0.00 |
$0 |
D/D |
(30,000) |
19,576 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2010-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,540 |
3,540 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
3,507 |
7,047 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2012-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
32,047 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2013-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
57,047 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
82,047 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2016-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2017-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2018-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
9,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2019-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
4,194 |
13,194 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2020-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,281 |
20,475 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2022-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,010 |
3,010 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2023-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,486 |
6,496 |
0 |
- |
|
| MGNX |
Macrogenics Inc |
Director |
– • – |
2024-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,500 |
4,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
|
– • – |
2024-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
4,790 |
11,286 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Exec. Vice President |
• • – |
2012-07-24 |
4 |
OE |
$0.52 |
$426,266 |
D/D |
68,701 |
88,277 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Exec. Vice President |
• – – |
2010-02-02 |
4 |
OE |
$12.56 |
$628,000 |
D/D |
50,000 |
69,576 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Exec. Vice President |
• – – |
2010-03-01 |
4 |
OE |
$12.56 |
$628,000 |
D/D |
50,000 |
69,576 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Exec. Vice President |
• – – |
2010-04-01 |
4 |
OE |
$12.56 |
$427,040 |
D/D |
34,000 |
53,576 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Exec. Vice President |
• • – |
2012-07-30 |
4 |
D |
$14.25 |
$278,958 |
I/I |
(19,576) |
0 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Exec. Vice President |
• • – |
2012-07-30 |
4 |
D |
$14.25 |
$978,989 |
D/D |
(68,701) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2020-07-02 |
4 |
D |
$18.00 |
$131,058 |
D/D |
(7,281) |
0 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2020-07-02 |
4 |
D |
$18.00 |
$237,492 |
D/D |
(13,194) |
0 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Exec. Vice President |
• – – |
2010-02-02 |
4 |
AS |
$27.40 |
$1,370,020 |
D/D |
(50,000) |
19,576 |
0 |
- |
|
27 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
